Skip to main content

Table 3 The summary of echocardiographic examination results of patients divided into CKD stage groups

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 3. Stage I/II Stage III Stage IV Stage V p
N=20 N=20 N=20 N=20
E/A 0.8 (0.8-1.1) 0.8 (0.7-0.95) 0.9 (0.8-1.2) 0.9 (0.8-1.3) NS
E/E’ 7.4±2.0 8.1±3.9 7.1±3.5 13.6±4.41,3,6 P=0.001
Diastolic dysfunction [%] 81.8 93.3 100.0 94.7 NS
Contractility disorders [%] 33.3 42.9 36.4 78.91,5 P=0.040
Mitral valve fibrosis [%] 81.8 80.0 70.6 90.5 NS
Aortic valve fibrosis [%] 9.1 20.0 23.5 4.8 NS
Mitral valve calcifications [%] 0 0 17.6 28.61 P=0.044
Aortic valve calcifications [%] 0 13.3 23.5 61.92,5 P=0.0008
IM [%] 54.5 50.0 58.8 81.0 NS
IA [%] 10.0 12.5 0 4.8 NS
IT [%] 27.3 25.0 37.5 71.41 P=0.016
  1. 1 p<0.05; 2 p<0.01 vs Stage I; 3 p<0.05; 4 p<0.01 vs Stage III; 5 P<0.05; 6 p<0.01 vs Stage IV